This report describes a rapid and simple method for mutation screening of G M1 gangliosidosis in Shiba dogs by direct amplification of DNA from canine whole-blood specimens using a novel polymerase chain reaction (PCR) reagent cocktail, which can eliminate the DNA extraction process and amplify the genomic DNA directly from human or murine whole blood. The strategy of this mutation screening is based on the identification of a nucleotide deletion by restriction enzyme analysis, coupled with the direct PCR amplification. The target sequence of the canine ␤-galactosidase gene could be amplified directly from various forms of canine whole-blood specimens, including anticoagulated blood, blood stored frozen for 1 year, dried blood held in filter paper for 1 year at room temperature, and dry powder of blood stripped from Giemsa-stained blood films, which had been prepared 10 years earlier, resulting in the determination of genotypes in all the specimens. This method simplified the molecular diagnosis and carrier screening of G M1 gangliosidosis in Shiba dogs, making it simple to examine specimens from the large, widely distributed population of these dogs.
G M1 gangliosidosis, a lysosomal disease that affects the brain and multiple systemic organs, is due to an autosomal recessively inherited deficiency of acid ␤galactosidase activity. 8 G M1 gangliosidosis in Shiba dogs was identified originally in 2000. 13 Since then, a closed breeding colony has been maintained at the Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan. 12 A homozygous recessive mutation causing G M1 gangliosidosis in Shiba dogs has been identified as the deletion of a cytosine residue at nucleotide position 1647 of the putative coding region for canine ␤-galactosidase, 10 which can be detected by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method using purified genomic DNA as a template. 10, 11 Hereafter, extensive genotyping studies of specimens from the large, widely distributed population of Shiba dogs are needed to control this canine disease and decrease the incidence rate. For this purpose, it is important that the genotyping test, including collection and delivery of the specimens, should become more rapid and easy.
Recently, a novel PCR reagent cocktail, which can eliminate the DNA extraction process and amplify the genomic DNA directly from human or murine whole blood, has been developed. 4, 5 This reagent has been used in genetic testing for some human diseases, 7,9 but, except for humans and mice, it has not been determined whether the reagent can be used for specimens of other animals. The present study demonstrated that this PCR reagent cocktail can be used for the mutation screening of G M1 gangliosidosis in Shiba dogs and also indicated some useful applications using various forms of whole-blood specimens from dogs and other domestic animals.
Shiba dogs of a pedigree with G M1 gangliosidosis 12 and normal Beagles as control were used in the present study. Venous blood was drawn into tubes a containing heparin lithium or ethylenediaminetetraacetic acid dipotassium salt (EDTA). The final concentration of heparin was adjusted to 25 IU/ml blood, but a specimen at a concentration of 250 IU/ml blood was also used to examine the effect of an overdose of heparin. The EDTA was used at a concentration of 1.56 mg/ml blood and also at an overdose (15.6 mg/ml blood). To examine the possible use of blood specimens, heparinized blood (25 IU/ml blood) was stored in a freezer at Ϫ20 C for 1 year. Also, the heparinized blood was dropped on a strip of sterile filter paper b and dried, and then the filter paper was stored in a dark room at room temperature for 1 year. In addition, specimens stripped from Giemsa-stained blood films of Shiba dogs, which had been prepared 10 years earlier, were also used for the mutation screening.
Polymerase chain reaction was carried out targeting a sequence in exon 15 of the canine ␤-galactosidase gene with forward (5Ј-AAC ACT GAG GAT GCA GTA CGC AGC-3Ј) and reverse (5Ј-TCC AGG AAA CTG GAT AAA GGT GTC-3Ј) primers in a 50-l reaction mixture containing 1ϫ Ampdirect-A, c 1.25 units of Taq polymerase, d 0.2 mM deoxynucleoside 5Јtriphosphate, and 25 pmol of the primers.
Canine whole-blood specimens, including anticoagulated blood, frozen blood, dried blood held in filter paper, and dry powder of blood stripped from blood films, were used directly as a template for the PCR amplification. The specimen of filter paper was cut into squares using an 18-gauge, disposable hypodermic needle and used as a template. Each whole-blood specimen other than the dry powder of blood was added to the reaction mixture without mixing, and the reaction tube was centrifuged at 2,000 ϫ g for a few seconds to ensure that the specimen reached the tube bottom. One drop of mineral oil was layered over the mixture, and the reaction was started immediately. The amount of each template added is shown in figure legends. On the other hand, the dry powder of blood, which was stripped with an 18-gauge needle from approximately 5 ϫ 5 mm of a blood film, was first put into an empty PCR tube and spun down on the tube bottom, and then the reaction mixture was layered over the specimen without mixing.
After preheating at 80 C for 15 minutes and the first denaturation at 94 C for 4.5 minutes, 30 cycles of amplification were carried out, at a denaturing temperature of 94 C for 30 seconds, an annealing temperature of 60 C for 1 minute, and an extension temperature of 72 C for 1 minute. Extension during the last cycle was carried out for 7 minutes. The amplification product (8 l) was added together with 5-20 units of the restriction endonuclease NciI e to a 10-l reaction mixture containing 1ϫ restriction endonuclease buffer and digested for 90 minutes at 37 C. Both the amplification and digested products were analyzed by 3% agarose gel electrophoresis, f stained with ethidium bromide, and detected using a UV transilluminator. A molecular weight standard g was used in the electrophoresis. This PCR-RFLP test was also carried out using another type of PCR reagent cocktail. h Because it was found that the target sequence of the canine ␤-galactosidase gene, which is a 185-bp sequence in the normal allele or a 184-bp sequence in the mutant allele, could be amplified directly from anticoagulated whole blood using both cocktails c,h (data not shown), all other examinations were carried out using the cocktail for human blood. c The target sequence was amplified directly from whole blood of both normal Beagles and Shiba dogs (Fig. 1A) . The type and dose of anticoagulants had no effect on the PCR amplification (Fig. 1A) . The DNA fragment was amplified when 0.1-6 l of heparinized blood was added to the reaction mixture as a template, but the blood volume ranging from 1 to 5 l seemed to afford the maximal amount of the PCR product (Fig. 1B) . When the products of the PCR were digested with NciI, a fragmentation pattern specific to each genotype was observed, resulting in the formation of 2 fragments (104 and 80 bp) in normal dogs, 3 fragments (184, 104, and 80 bp) in heterozygous carriers, and 1 fragment (184 bp) in homozygous dogs (Fig. 1C) .
Heparinized blood stored at Ϫ20 C for 1 year could also be successfully analyzed using this mutation screening (data not shown). Using dried blood held in filter paper with an area ranging from 0.5 ϫ 0.5 mm to 5 ϫ 5 mm as a template, the target DNA fragment could be amplified ( Fig. 2A) . Dried blood held in filter paper, which was stored at room temperature for 1 year, could also be used successfully for the mutation screening (Fig. 2B ). In addition, the mutation screening could be performed using dry powder of canine blood stripped from a blood film, which had been prepared 10 years earlier (data not shown).
Blood specimens contain a variety of substances that inhibit PCR, such as heme, 1 immunoglobulin, 2 and anticoagulants, including heparin 3 and EDTA. 6 The PCR reagent cocktail used in the present study neutralizes these various charge-bearing inhibitory substances that might otherwise bind to DNA polymerase and template DNA and thus inhibit PCR 4,5 and consequently eliminates the DNA extraction process involving multiple labor-intensive steps. Using this cocktail, all the canine blood specimens used in the present study gave the predicted PCR product for the genotyping of G M1 gangliosidosis in Shiba dogs. Therefore, the PCR reagent cocktail, which was originally developed for genetic testing using human or murine blood specimens, has been found to be useful for genetic testing using canine blood specimens. When PCR targeting the human ␤-globin gene was performed, more than 2.5 l of heparinized human blood did not give the predicted PCR product because of prevention of PCR by inhibitors, and more than 40 cycles of the reaction were necessary to amplify the predicted PCR product from 1 l of human blood. 4 In Figure 1 . A, The PCR amplification directly from canine whole blood treated with heparin lithium or EDTA. One microliter of whole blood from a Beagle or a Shiba dog was used as a template. The concentration of heparin was 25 (L) or 250 IU/ml of blood (H), and the concentration of EDTA was 1.56 (L) or 15.6 mg/ml of blood (H). Lane M shows molecular size markers. B, PCR amplification directly from whole blood that was collected from a Beagle using heparin lithium (25 IU/ml of blood) as an anticoagulant. The amount of blood used as a template ranged from 0.1 to 6 l and is shown at the top of each lane. Lane M shows molecular size markers. C, Genotyping of a normal Beagle, normal, heterozygous carrier, and homozygous affected Shiba dogs in the pedigree with G M1 gangliosidosis by DNA mutation screening using the PCR-RFLP test. The PCR was performed directly from whole blood that was collected using heparin lithium (25 IU/ml of blood) as an anticoagulant. The amplified DNA without digestion (N) and digested with restriction endonuclease NciI (D) was analyzed simultaneously. Lane M shows molecular size markers.
Figure 2. A,
The PCR amplification directly from dried canine blood held in filter paper. The area of the filter paper used as a template ranged from 0.5 ϫ 0.5 mm to 5 ϫ 5 mm and is shown at the top of each lane. Lane M shows molecular size markers. B, Genotyping of normal, heterozygous carrier and homozygous affected Shiba dogs in the pedigree with G M1 gangliosidosis by DNA mutation screening using the PCR-RFLP test. The PCR was performed directly from dried blood held in filter paper that had been stored at room temperature for 1 year. The amplified DNA without digestion (N) and digested with restriction endonuclease NciI (D) was analyzed simultaneously. Lane M shows molecular size markers. the present study, however, using 0.1-6 l of heparinized canine blood, 30 cycles of the reaction produced the predicted PCR product, suggesting that there may be lower levels of inhibitory substances in canine blood than in human blood. Furthermore, a preliminary study by these authors also showed that the cocktail makes it possible to amplify genomic DNA directly from whole-blood specimens of cats and cattle (Osamu Yamoto, unpublished data). Therefore, this cocktail is a convenient reagent that makes various genetic tests simple and easy not only in the areas of human and experimental medicine but also in veterinary medicine and genetics of domestic animals.
For archiving or transport of blood samples, it is convenient to use dried blood. In the present study, it was shown that dried canine blood held in filter paper can be used for the mutation screening of canine G M1 gangliosidosis even if 1 year has passed since the sample collection. Furthermore, it was also shown that stained blood films can be used for this genetic testing even if 10 years have passed since the sample preparation. Therefore, the method used for genetic testing in the present study makes it easy to examine specimens from the large, widely distributed populations. It has been suggested that the mutant allele causing canine G M1 gangliosidosis is distributed widely in breeding colonies of Shiba dogs all over Japan and may have been transported to North America, Europe, and Australia. 12 The method described here will contribute to epidemiologic and retrospective studies with the aim of controlling this canine disease.
